ADCT
ADC Therapeutics SA
stockNYSE
Market OpenNov 13, 2026 2:32:27 PM EST
1.40USD-0.355%(-0.01)770,665
Pre-marketNov 13, 2026 9:20:30 AM EST
1.41USD0.000%(0.00)
ADCT Financials
In Q3 FY 2026 (ended ), ADC Therapeutics SA (ADCT) reported revenue of $21.72M, net income of −$25.3M, operating cash flow of −$27.88M, and assets of $255.86M (filed ).
Loading financial statements…